Release Notes:
Data Element
Version 2018A
| Data Element Name: |
Reason for Oral Factor Xa Inhibitor |
|---|
| Collected For: |
STK-1 |
|---|
| Definition: | Documentation why Oral Factor Xa Inhibitor was administered for VTE prophylaxis. |
|---|
| Suggested Data Collection Question: | Is there physician/APN/PA or pharmacist documentation why Oral Factor Xa Inhibitor was administered for VTE prophylaxis? |
|---|
| Format: |
| Length: | 1 |
|---|
| Type: | Alphanumeric |
|---|
| Occurs: | 1 |
|---|
|
|---|
| Allowable Values: |
Y (Yes) There is physician/APN/PA or pharmacist documentation why Oral Factor Xa Inhibitor was administered for VTE Prophylaxis.
N (No) There is no physician/APN/PA or pharmacist documentation why Oral Factor Xa Inhibitor was administered for VTE Prophylaxis, OR unable to determine from the medical record documentation.
|
|---|
| Notes for Abstraction: |
- The only acceptable reasons are identified in the list of inclusions. No other reasons will be accepted.
- History of atrial fibrillation/flutter or current finding of atrial fibrillation/flutter, select “Yes.”
- History of hip or knee replacement surgery, select “Yes.”
- When conflicting information is documented in the medical record, select “Yes.”
- History of treatment for venous thromboembolism or current treatment for venous thromboembolism, select “Yes.”
|
|---|
| Suggested Data Sources: |
PHYSICIAN/APN/PA or PHARMACIST DOCUMENTATION ONLY IN THE FOLLOWING ONLY ACCEPTABLE SOURCES:
- Anesthesia record
- Consultation notes
- Emergency Department record
- History and physical
- Operative Note
- Physician orders
- Progress notes
- Risk assessment form
- Transfer sheet
|
|---|
| Additional Notes: |
|
|---|
| Guidelines for Abstraction: |
|---|
| Inclusion |
Exclusion |
This list is all inclusive
- AF
- A-fib
- Atrial fibrillation
- Atrial flutter
- History of any remote episode of documented atrial fibrillation or flutter except within 8 weeks following CABG
- PAF
- Paroxysmal atrial fibrillation
- Partial hip arthroplasty
- Partial hip replacement
- Persistent atrial fibrillation
- THR
- TKR
- Total hip arthroplasty
- Total hip replacement
- Total knee arthroplasty
- Total knee replacement
- Treatment of venous thromboembolism
|
- Hip fracture
- History of atrial fibrillation or flutter that terminated within 8 weeks following CABG
- History of transient and entirely reversible episode of documented atrial fibrillation or flutter due to thyrotoxicosis
- PAC
- Paroxysmal atrial tachycardia
- Paroxysmal supraventricular tachycardia
- PAT
- Premature atrial contraction
- PST
|
|
Reason for Oral Factor Xa Inhibitor
Specifications Manual for Joint Commission National Quality Measures (v2018A)
Discharges 07-01-18 (3Q18) through 12-31-18 (4Q18)
^